Market Closed -
Other stock markets
|
Pre-market 05:11:27 pm | |||
53.81 USD | +1.55% | 54.7 | +1.66% |
18/04 | Citigroup Adjusts CRISPR Therapeutics' Price Target to $89 From $88, Keeps Buy Rating | MT |
17/04 | Crispr Therapeutics Insider Sold Shares Worth $1,173,232, According to a Recent SEC Filing | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-14.04% | 4.57B | |
+0.67% | 42.4B | |
+46.73% | 40.04B | |
-6.20% | 28.31B | |
+6.55% | 24.94B | |
-21.66% | 18.96B | |
+29.96% | 12.3B | |
-1.57% | 11.95B | |
+16.03% | 11.32B | |
-4.80% | 11.55B |
- Stock Market
- Equities
- CRSP Stock
- News CRISPR Therapeutics AG
- Insider Trends: Selling By Insiders Lingers at CRISPR Therapeutics